PAR – Paradigm Biopharmaceuticals Limited
You always have to be careful with biotechs, they have plenty of specific risks. PAR is unusual because the drug doesnt need the extensive approval process that applies to new drugs, hence the ease with which they were able to set up a Special Access Scheme and get so many people using Zilosul. I am…